<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To study the correlation between high <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>-associated protein 1 (MTA1) expression and lymphangiogenesis in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and its role in production of vascular endothelial growth factor-C(VEGF-C) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Impact of high MTA1 and VEGF-C expression levels on disease progression and lymphovascular density (LVD, D2-40-immunolabeled) in 81 cases of human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> was evaluated by immunohistochemistry </plain></SENT>
<SENT sid="2" pm="."><plain>VEGF-C <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expressions in human LoVo and HCT116 cell lines were detected by real-time polymerase chain reaction and Western blotting, respectively, with a stable expression vector or siRNA </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The elevated MTA1 and VEGF-C expression levels were correlated with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and Dukes stages (P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>Additionally, high MTA1 expression level was correlated with a large <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size (P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>A significant correlation was found between MTA1 and VEGF-C protein expressions in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells (r = 0.371, P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Similar to the VEGF-C expression level, high MTA1 expression level was correlated with high LVD in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, over-expression of MTA1 significantly enhanced the VEGF-C <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression levels, whereas siRNAs - knocked down MTA1 decreased the VEGF-C expression level </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: MTA1, as a regulator of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated lymphangiogenesis, promotes lymphangiogenesis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> by mediating the VEGF-C expression </plain></SENT>
</text></document>